TABLE 1.
Measures | Controls | MTBI Patients | P-value |
---|---|---|---|
FA | 0.23 ±0.02 | 0.22 ±0.02 | 0.5733 |
MD | 1.40 ±0.14 | 1.37 ±0.12 | 0.4648 |
MK | 0.84 ±0.04 | 0.81 ±0.04 | 0.0092 |
Krad | 0.93 ±0.05 | 0.88 ±0.07 | 0.0078 |
Kax | 0.72 ±0.04 | 0.70 ±0.03 | 0.1528 |
Measures | Controls | MTBI Patients | P-value |
---|---|---|---|
FA | 0.23 ±0.02 | 0.22 ±0.02 | 0.5733 |
MD | 1.40 ±0.14 | 1.37 ±0.12 | 0.4648 |
MK | 0.84 ±0.04 | 0.81 ±0.04 | 0.0092 |
Krad | 0.93 ±0.05 | 0.88 ±0.07 | 0.0078 |
Kax | 0.72 ±0.04 | 0.70 ±0.03 | 0.1528 |